Claudia Hawkins, MD will oversee all oversees all aspects of this study including development of the protocol and adherence to protocol guidelines; preparation of progress reports; site/lab preparations and execution of CTA(s); communication with sites; protocol revisions; analysis, data reporting and manuscript preparation.
|Effective start/end date||12/1/20 → 11/30/22|
- University of California at Los Angeles (1560 G YB704 Amnd 2//2UM1AI068636-16)
- National Institute of Allergy and Infectious Diseases (1560 G YB704 Amnd 2//2UM1AI068636-16)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.